🇺🇸 FDA

Company profile · Sponsor

Myovant

Myovant Sciences GmbH

C1B3B80 · NMPA pharma CN
Pipeline
1
Drugs
0
Patents
0

Quick answer

Myovant (C1B3B80) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C1B3B80
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (1)

Search pipeline →

  1. Relugolix

    Myovant

    Prostate Cancer

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is Myovant?

Myovant (C1B3B80) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Myovant sponsor?

We track 1 ClinicalTrials.gov-linked program for Myovant, including Relugolix. Open each program for phase, modality, NCT IDs, and indication details.

Where does Myovant company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.